Affiliation:
1. School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA
2. School of Pharmacy and Bioengineering, Chongqing University of Technology, Pittsburgh, PA 15261, USA
3. Computational Drug Abuse Research and Computational Chemogenomics Screening Center at the University of Pittsburgh, Pittsburgh, PA 15261, USA
Abstract
Abstract
The design of therapeutic antibodies has attracted a large amount of attention over the years. Antibodies are widely used to treat many diseases due to their high efficiency and low risk of adverse events. However, the experimental methods of antibody design are time-consuming and expensive. Although computational antibody design techniques have had significant advances in the past years, there are still some challenges that need to be solved, such as the flexibility of antigen structure, the lack of antibody structural data and the absence of standard antibody design protocol. In the present work, we elaborated on an in silico antibody design protocol for users to easily perform computer-aided antibody design. First, the Rosetta web server will be applied to generate the 3D structure of query antibodies if there is no structural information available. Then, two-step docking will be used to identify the binding pose of an antibody–antigen complex when the binding information is unknown. ClusPro is the first method to be used to conduct the global docking, and SnugDock is applied for the local docking. Sequentially, based on the predicted binding poses, in silico alanine scanning will be used to predict the potential hotspots (or key residues). Finally, computational affinity maturation protocol will be used to modify the structure of antibodies to theoretically increase their affinity and stability, which will be further validated by the bioassays in the future. As a proof of concept, we redesigned antibody D44.1 and compared it with previously reported data in order to validate IsAb protocol. To further illustrate our proposed protocol, we used cemiplimab antibody, a PD-1 checkpoint inhibitor, as an example to showcase a step-by-step tutorial.
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Molecular Biology,Information Systems
Reference76 articles.
1. Immunotherapy for drug abuse;Shen;CNS Neurol Disord Drug Targets,2011
2. Review of COVID-19 antibody therapies;Chen;Annu Rev Biophys,2020
3. Understanding antibody testing for COVID-19;Jacofsky;J Arthroplasty,2020
4. Development of therapeutic antibodies for the treatment of diseases;Lu;J Biomed Sci,2020
5. Theoretical and computational protein design;Samish;Annu Rev Phys Chem,2011
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献